Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Patent
1981-12-28
1984-02-21
Chan, Nicky
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C07D31178
Patent
active
044331584
ABSTRACT:
Novel 3-hydroxyiminoscirpen-4.beta., 15-diol esters and derivatives thereof are provided for use as antitumor agents. Also provided are processes for producing the above compounds and methods for using them to inhibit malignant tumors in mammals.
REFERENCES:
patent: 3428652 (1969-02-01), Sigg et al.
patent: 4129577 (1978-12-01), Ellison et al.
patent: 4332732 (1982-06-01), Schmitz et al.
patent: 4352936 (1982-10-01), Kaneko
Helvetica Chimica Acta 48:962-988 (1965).
Pathre et al., Journ. Agric. Food Chem. 24(1): 97-103 (1976).
Grove, Journ. Chem. Soc. (C), pp. 375-379 (1970).
Grove et al., Biochemical Pharm. 24, pp. 959-962 (1972).
Wei et al., Biochem. and Biophys. Res. Comm. 57(3), pp. 838-844 (1974).
Flury et al., Chem. Comm., pp. 26-27 (Nov. 2, 1965).
Dawkins et al., Journ. Chem. Soc. (C), 369-375 (1970).
Doyle Terrence W.
Essery John M.
Kaneko Takushi
Schmitz Henry
Bristol-Myers Company
Chan Nicky
Morse David M.
LandOfFree
3-Hydroxyiminoscirpen-4.beta., 15-diol esters useful as antitumo does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3-Hydroxyiminoscirpen-4.beta., 15-diol esters useful as antitumo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-Hydroxyiminoscirpen-4.beta., 15-diol esters useful as antitumo will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1036911